Imigran Australia tablets are generally prescribed in cases of migraine attacks, with or without aura, hence Imigran should only be applied when there is a confirmed and diagnosed migraine. Imigran Australia is a 50mg capsule-shaped tablet, pink in colour, film-coated, with engraving “GX ES3”. It is best to take Imigran Australia without exceeding the prescribed dosage and as acute intermittent migraine treatment only. Imigran should be taken at early stages when the signs migraine attack just start appearing. However, the medicine has proved to be effective at any stage of migraine attack. The recommended oral dosage of Imigran Australia is a 50mg tablet. Certain patients may require a 100mg dose, but only with a doctor’s permission. In general, the overall Imigran dose should not exceed 300 mg within 24 hours and should be taken with water and a minimum interval of 2 hours in between each intake.

In case, if a patient does not respond to the prescribed Imigran dose during migraine attack, the second dose should not be taken and further consultation with a doctor should be appointed. Basically, Imigran should be as monotherapy for migraine treatment and should not be mixed with ergotamine or its derivatives (i.e. methysergide).

Side Effects

Please make sure you carefully read through and familiarize yourself with the list of side effects that may be caused by Imigran. This will ensure that you continue taking this medicine in a safe manner throughout the entire treatment period. The following are possible side effects:

• Nervous System Disorders – drowsiness, dizziness, hypoaesthesia, paraesthesia and other sensory disturbances;
• Vascular Disorders – increase in blood pressure, flushing etc;
• Respiratory, Thoracic and Mediastinal Disorders – dyspnoea;
• Musculoskeletal and Connective Tissue Disorders – heaviness sensations (may affect chest, throat or any other body part);
• Gastrointestinal Disorders – vomiting and nausea. The study has shown that certain patients have experienced nausea or vomiting, but it is still unclear, whether such reaction is related to sumatriptan or the underlying condition itself;
• Respiratory, Mediastinal and Thoracic Disorders – dyspnoea;
• General Disorders & Administration Site Conditions – pain is certain body parts, sensations of pressure or tightness, heat or cold, weakness, fatigue etc.;

Precautions

Sumatriptan (constituent of Imigran Australia) should not be taken by patients with myocardial infarction or coronary vasospasm, peripheral vascular disease or with symptoms of ischaemic heart disease. Patients with cerebovascular accident (CVA) or transient ischaemic attack (TIA) should abstain from taking Imigran as well.

Moreover, patients experiencing severe hepatic impairment should not take Sumatriptan and should get immediate consultation with doctor. In case, if you experience moderate or severe hypertension, please do not take this medicine as well. In addition, Imigran does not react well with monoamine oxidase inhibitors and should be avoided.

Imigran is to be taken only when a clear diagnosis of migraine takes place. Other types of migraine (e.g. hemiplegic, basilar or ophthalmoplegic) should not be treated with Imigran Australia.

The age restrictions include children younger than 17 years old and elderly patients older than 65 years old. Hereby, please ensure you undergo a consultation with a certified physician prior to taking Imigran Australia.

Patients with lactose intolerance, the Lapp lactase deficiency as well as glucose-galactose malabsorption should abstain from taking this medicine, because it contains lactose.

Pregnant and breastfeeding ladies should undergo a detailed consultation with a doctor prior to taking Imigran Australia. In case if any additional information is required, please do not hesitate to obtain it from physician or online. Otherwise, do not hesitate to contact the customer support for more info.